ascopubs.org6d
Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
ascopubs.org8d
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis: One Decade Later
In 2012, the National Academies of Sciences, Engineering, and Medicine convened a committee charged with addressing the quality of cancer care in the United States and providing recommendations to ...
ascopubs.org10d
Optimizing access to care for new patients with cancer discharged from an observation unit.
Understanding the impact of historical redlining on prostate cancer care quality and treatment patterns and the association with modern metrics of disparity. Time interval for new patients to acquire ...
ascopubs.org7d
Impact of Cancer Across the Intergenerational Family: A Multidimensional Perspective From African Countries
This commentary explores the intergenerational (affecting and involving multiple generations) harm caused by cancer and cancer-related deaths in African countries, particularly cancer and ...
ascopubs.org13d
Patient Enrollment to Industry-Sponsored Versus Federally Sponsored Cancer Clinical Trials
The conduct of cancer clinical research in the United States is supported by both private and public sponsors. Industry aims to obtain new drug approvals. Federally sponsored trials examine a broad ...
ascopubs.org10d
Hurricane disasters and radiation treatment delays among patients diagnosed with non-small cell lung cancer.
Impact of a care delivery intervention for patients with socioeconomic disadvantages, in their preferred language of English or Spanish. This is an ASCO Meeting Abstract from the 2024 ASCO Quality ...
ascopubs.org6d
Reply to C. Fuchao et al
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
ascopubs.org7d
Stockholm3 in a Multiethnic Cohort: Optimizing Prostate Cancer Screening to Reduce Harm and Improve Equity
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 In the article that ...
ascopubs.org10d
Effects of loneliness on healthcare utilization and medical expenditures in US cancer survivors.
Enhancing screening for nutritional causes of anemia in hospitalized patients with cancer.
ascopubs.org8d
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma Using pooled ...
ascopubs.org9d
On the Nose: Reducing Nasopharyngeal Cancer–Related Mortality Using Risk-Based Epstein-Barr Virus Serology Screening
The study demonstrated that a risk-based screening algorithm for nasopharyngeal cancer (NPC) control in a high-risk population is effective, and several refinements to this algorithm to improve ...
ascopubs.org9d
Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
When You Get to the Fork in the Road, Take It: The Challenges in Managing Patients With Advanced Prostate Cancer A multi-institution retrospective study of patients with mTNBC treated with SG from ...